CRISPR Medicine News

CRISPR Medicine News

About CRISPR Medicine News

Welcome to CRISPR Medicine News.
We are a global independent online media writing about gene therapy and genome editing.

Read more.

Learn - Innovate - Access

CLINICAL TRIALS
Beta-Thalassemia, (NCT06717932)
Sponsors:
CorrectSequence Therapeutics Co., Ltd  
IND Enabling
Phase I
Phase II
Phase III
Beta-Thalassemia, (NCT06685536)
Sponsors:
CorrectSequence Therapeutics Co., Ltd
IND Enabling
Phase I
Phase II
Phase III
Familial Chylomicronemia Syndrome, FCS, (NCT07176923)
Sponsors:
CorrectSequence Therapeutics Co., Ltd
Indicator
IND Enabling
Phase I
Phase II
Phase III
View all clinical trials
CRISPR Medicine News
Harvard Medical School (@HMS)

Genome Engineering Seminar Series (GESS)

Read more...Harvard Medical School (@HMS)
Join WDC Chat Community
WDC Chat Community
close
Search CRISPR Medicine